Bromperidol maintenance in schizophrenia.

Journal Article

Twenty-three patients who completed a four-week, double-blind, clinical trial of bromperidol versus haloperidol were treated with bromperidol for eight additional weeks in a continuation study. Over 87 percent of patients maintained their improved status or showed further improvement. Extrapyramidal signs were frequent, but required discontinuation of treatment in only two patients.

Duke Authors

Cited Authors

  • McEvoy, JP; Wilson, WH; Ban, TA; Brannen, JO; Berney, S

Published Date

  • 1982

Published In

  • Pharmacopsychiatria

Volume / Issue

  • 15 / 3

Start / End Page

  • 95 - 96